The Chemours Company - Laporan Laba Rugi (TTM)

The Chemours Company
US ˙ NYSE ˙ US1638511089

Laporan Laba Rugi (TTM)

Laporan Laba Rugi The Chemours Company menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 4,984 4,969 5,100 5,662 6,108 6,345 6,673 6,933 7,031 6,831 6,566 6,294 6,004 6,078 5,904 5,814 5,828 5,782 5,788 5,850
Change (%) -0.30 2.64 11.02 7.88 3.88 5.17 3.90 1.41 -2.84 -3.88 -4.14 -4.61 1.23 -2.86 -1.52 0.24 -0.79 0.10 1.07
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 4,080 3,902 4,034 4,531 4,807 4,964 5,103 5,131 5,224 5,215 5,068 4,882 4,751 4,772 4,682 4,694 4,695 4,631 4,685 4,777
Change (%) -4.36 3.38 12.32 6.09 3.27 2.80 0.55 1.81 -0.17 -2.82 -3.67 -2.68 0.44 -1.89 0.26 0.02 -1.36 1.17 1.96
% of Revenue 81.86 78.53 79.10 80.02 78.70 78.23 76.47 74.01 74.30 76.34 77.19 77.57 79.13 78.51 79.30 80.74 80.56 80.09 80.94 81.66
Gross Operating Profit 904 1,067 1,066 1,131 1,301 1,381 1,570 1,802 1,807 1,616 1,498 1,412 1,253 1,306 1,222 1,120 1,133 1,151 1,103 1,073
Change (%) 18.03 -0.09 6.10 15.03 6.15 13.69 14.78 0.28 -10.57 -7.30 -5.74 -11.26 4.23 -6.43 -8.35 1.16 1.59 -4.17 -2.72
% of Revenue 18.14 21.47 20.90 19.98 21.30 21.77 23.53 25.99 25.70 23.66 22.81 22.43 20.87 21.49 20.70 19.26 19.44 19.91 19.06 18.34
SG&A 463 526 539 572 582 583 560 670 688 705 689 624 567 526 538 505 532 602 587 611
Change (%) 13.61 2.47 6.12 1.75 0.17 -3.95 19.64 2.69 2.47 -2.27 -9.43 -9.13 -7.23 2.28 -6.13 5.35 13.16 -2.49 4.09
% of Revenue 9.29 10.59 10.57 10.10 9.53 9.19 8.39 9.66 9.79 10.32 10.49 9.91 9.44 8.65 9.11 8.69 9.13 10.41 10.14 10.44
R&D 86 93 93 100 104 107 113 111 117 118 114 117 112 108 110 107 108 109 108 111
Change (%) 8.14 0.00 7.53 4.00 2.88 5.61 -1.77 5.41 0.85 -3.39 2.63 -4.27 -3.57 1.85 -2.73 0.93 0.93 -0.92 2.78
% of Revenue 1.73 1.87 1.82 1.77 1.70 1.69 1.69 1.60 1.66 1.73 1.74 1.86 1.87 1.78 1.86 1.84 1.85 1.89 1.87 1.90
OpEx 4,629 4,522 4,667 5,204 5,494 5,654 5,777 5,913 6,030 6,038 5,871 5,623 5,430 5,406 5,330 5,306 5,335 5,342 5,380 5,499
Change (%) -2.31 3.21 11.51 5.57 2.91 2.18 2.35 1.98 0.13 -2.77 -4.22 -3.43 -0.44 -1.41 -0.45 0.55 0.13 0.71 2.21
% of Revenue 92.88 91.00 91.51 91.91 89.95 89.11 86.57 85.29 85.76 88.39 89.42 89.34 90.44 88.94 90.28 91.26 91.54 92.39 92.95 94.00
Operating Income 355 447 433 458 614 691 896 1,020 1,001 793 695 671 574 672 574 508 493 440 408 351
Change (%) 25.92 -3.13 5.77 34.06 12.54 29.67 13.84 -1.86 -20.78 -12.36 -3.45 -14.46 17.07 -14.58 -11.50 -2.95 -10.75 -7.27 -13.97
% of Revenue 7.12 9.00 8.49 8.09 10.05 10.89 13.43 14.71 14.24 11.61 10.58 10.66 9.56 11.06 9.72 8.74 8.46 7.61 7.05 6.00
Interest Expense -212 -210 -205 -200 -192 -185 -177 -170 -166 -163 -164 -171 -185 -208 -229 -246 -260 -264 -267 -269
Change (%) -0.94 -2.38 -2.44 -4.00 -3.65 -4.32 -3.95 -2.35 -1.81 0.61 4.27 8.19 12.43 10.10 7.42 5.69 1.54 1.14 0.75
% of Revenue -4.25 -4.23 -4.02 -3.53 -3.14 -2.92 -2.65 -2.45 -2.36 -2.39 -2.50 -2.72 -3.08 -3.42 -3.88 -4.23 -4.46 -4.57 -4.61 -4.60
Net Income -117 219 215 256 394 608 746 881 908 578 489 -87 -317 -238 -329 106 68 86 28 -412
Change (%) -287.18 -1.83 19.07 53.91 54.31 22.70 18.10 3.06 -36.34 -15.40 -117.79 264.37 -24.92 38.24 -132.22 -35.85 26.47 -67.44 -1,571.43
% of Revenue -2.35 4.41 4.22 4.52 6.45 9.58 11.18 12.71 12.91 8.46 7.45 -1.38 -5.28 -3.92 -5.57 1.82 1.17 1.49 0.48 -7.04

Source: Capital IQ

Other Listings
GB:0HWG US$ 15.63
MX:CC
AT:CHEM
DE:2CU € 12.78
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista